Innovative drug ETF wealth country: Two-tier market trading price premium risk

The Innovative Medicine ETF Fund of Fortune announced that the secondary market trading price of the fund has recently been significantly higher than the net asset value per share, resulting in a large premium. On July 1, 2026, the closing price was 0.793 yuan, while the net asset value per share at closing was 0.7365 yuan. If the premium does not effectively decrease on July 2, the fund has the right to apply for measures such as temporary trading suspension during trading hours. Investors can trade on the secondary market or subscribe and redeem shares of the fund. The trading price is influenced by various factors and may result in losses. Currently, the fund is operating normally and there is no undisclosed significant information that should be disclosed.